Press Release — 2024.08.01
Emeraid, Inc. (Headquarters: Bunkyo-ku, Tokyo; CEO: Rikuto Shima), a University of Tokyo startup challenging the optimization and sustainability of the medical and healthcare industry through AI-DX using cutting-edge technologies, has been commissioned to develop a mockup application for the research project "Construction of a Death Time Prediction Model through Patient Information Analysis" conducted at Yokohama City University (Location: Yokohama, Kanagawa / President: Yoshihiro Ishikawa). This application will be used as part of the research outcomes and for future model improvements.
For inquiries about medical research support or application development, please feel free to contact us.
Associate Professor / Head of Intensive Care Unit, Yokohama City University Faculty of Medicine
Dr. Shunsuke Takagi
I felt that the data scientists and engineers skillfully interpreted the requests of healthcare professionals and created a mockup that met our expectations. Based on the results of this work, we would like to continue working with Emeraid on various initiatives going forward.
CEO, Emeraid, Inc.
Rikuto Shima
We were given the opportunity to explore appropriate interfaces for healthcare professionals regarding the theme of prognostic prediction. As we steadily work step by step toward the grand vision of realizing a new form of patient-centered medicine through technology, we hope to find more opportunities to leverage our expertise. Going forward, Emeraid will continue to promote joint research with universities, medical institutions, and companies in the medical industry through our "problem-oriented AI-DX" technology, striving to realize a society where everyone can face "living" head-on.